SCHEMBL19028014

SCHEMBL19028014

CC(=O)NNc1cc(N2CCCCC2)ncn1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.55
ALDH1A1 P00352 3/20 0.53
RAB9A P51151 3/20 0.53
GAA P10253 3/20 0.48
KDM4E B2RXH2 1/20 0.48
MEN1 O00255 1/20 0.48
THRB P10828 1/20 0.48
KMT2A Q03164 1/20 0.48
APAF1 O14727 2/20 0.45
MAPT P10636 2/20 0.45
PPP1CA P62136 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
HRH4 Q9H3N8 5/20 0.43
HRH3 Q9Y5N1 2/20 0.43
HTT P42858 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA1 P30542 1/20 0.43
NPC1 O15118 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5144566 0.75 NUDT1 (0.56) SMN1; SMN2ALDH1A1RAB9AHRH4HRH3
SCHEMBL2567649 0.73 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1RAB9AHRH4HRH3
SCHEMBL28825916 0.72 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1RAB9AHRH4HRH3
SCHEMBL19548104 0.72 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1RAB9AHRH4NPC1
SCHEMBL3819188 0.72 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1RAB9AHRH4HRH3
SCHEMBL16840691 0.72 HRH4 (0.55) SMN1; SMN2ALDH1A1RAB9AHRH4HRH3
SCHEMBL5090089 0.70 HRH4 (0.55) SMN1; SMN2ALDH1A1RAB9AHRH4HRH3
SCHEMBL16589234 0.70 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1RAB9AGAAKDM4E
SCHEMBL18654939 0.70 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1RAB9AKDM4EMEN1
SCHEMBL12168416 0.69 KMO (0.71) SMN1; SMN2ALDH1A1RAB9ANPC1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2847183-B1 PROCESS FOR THE PREPARATION OF TRIAZOLE COMPOUNDS Bayer Pharma AG (DE) 2017-06-21 EP disclosed